Cognition Therapeutics Inc (NAS:CGTX)
$ 0.84 0.0726 (9.46%) Market Cap: 34.90 Mil Enterprise Value: 10.45 Mil PE Ratio: 0 PB Ratio: 2.37 GF Score: 28/100

Q4 2023 Cognition Therapeutics Inc Earnings Call Transcript

Mar 26, 2024 / 12:00PM GMT
Release Date Price: $1.83 (+0.55%)
Operator

Hello, everyone, and welcome to Cognition Therapeutics fourth quarter 2023 earnings call. Please note that this call is being recorded. I'd now like to hand over to our first speaker for today, Mike Moyer. Please go ahead.

Mike Moyer
Lifesci Advisors, LLC - IR

Thank you, operator, and good morning, everyone. Welcome to the Cognition Therapeutics fourth quarter and year end 2023 results conference call. With me today are Lisa Ricciardi, President and Chief Executive Officer; John Doyle, Chief Financial Officer; and Dr. Tony Caggiano, Chief Medical Officer.

This morning the company issued a press release detailing its 2023 fourth quarter and year-end results. We encourage everyone to read this morning's press release as well as Cognition's annual report on Form 10-K, which is now filed with the SEC and available on our website. In addition, this conference call is being webcast through the company's website and will be archived for 30 days.

Please note that certain information discussed on the call today is covered under the Safe Harbor

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot